IP Library › Assignment 064132/0352
Patent Assignment
Reel/Frame 064132/0352

Assignment of Assignor's Interest

Recorded: 2023-06-30 Pages: 9
Assignor
NOVARTIS PHARMA AG
Executed: 2023-06-26
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties (4)
Use of Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma), as Agents for the Treatment of Prostate Cancer
Application: 17/143,280 →
Publication: US 2021/0283279
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma) as Agents for the Treatment of Prostate Cancer
Application: 17/110,558 →
Publication: US 2021/0177996
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma), Their Use as Imaging Agents and Pharmaceutical Agents for the Treatment of Prostate Cancer
Application: 16/038,729 →
Publication: US 2019/0008988
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma) as Agents for the Treatment of Prostate Cancer
Application: 16/551,198 →
Publication: US 2019/0374660
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 29, 2018
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 046737/0135 →
Assignment of Assignor's Interest Aug 29, 2018
From: KLIEM, HANS-CHRISTIAN
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 046969/0540 →
Assignment of Assignor's Interest Aug 29, 2018
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 046732/0661 →
Assignment of Assignor's Interest Oct 12, 2018
From: KRATOCHWIL, CLEMENS
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 047146/0548 →
Confirmation of Ownership (as Filing Relates to Compounds That Are "Derivatives") Dec 20, 2018
From: UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.
Reel/Frame 047972/0664 →
Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No 16/038,729 at Reel 047972/Frame 0664 Nov 12, 2019
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 050993/0581 →
Declaration to Correct Assignment Record Following Declaration Recorded on November 12, 2019 in Application No. 16/038,729 Feb 21, 2020
From: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
Reel/Frame 051989/0869 →
Confirmation of Ownership (as Filing Relates to Compounds That Are "Derivatives") Feb 21, 2020
From: UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.
Reel/Frame 051989/0187 →
Assignment of Assignor's Interest Mar 13, 2020
From: KRATOCHWIL, CLEMENS
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 052107/0330 →
Assignment of Assignor's Interest Mar 13, 2020
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 052107/0134 →
Assignment of Assignor's Interest Mar 13, 2020
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 052107/0396 →
Assignment of Assignor's Interest Dec 3, 2020
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 054530/0239 →
Assignment of Assignor's Interest Dec 3, 2020
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 054530/0342 →
Confirmation of Ownership (as Filing Relates to Compounds That Are "Derivatives") Feb 9, 2021
From: UNIVERSITY OF HEIDELBERG
To: UNIVERSITY OF HEIDELBERG; MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Reel/Frame 055266/0204 →
Assignment of Assignor's Interest Jun 6, 2021
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 056448/0833 →
Assignment of Assignor's Interest Jun 6, 2021
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 056448/0827 →
Corrective Assignment to Correct the 16/551/198 Corrected Assignment Record After Attempt by a Thrid Party Also Second Receiving Party Added Previously Recorded at Reel: 051989 Frame: 0187. Assignor(S) Hereby Confirms the Assingment. Nov 20, 2021
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 058567/0798 →
Second Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No. 16/038,729 at Reel 051989/Frame 0869 Feb 9, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059098/0285 →
Declaration of Brenda Herschbach Jarrell Apr 12, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059690/0227 →
Declaration of Brenda Herschbach Jarrell Apr 12, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059690/0237 →
Nunc Pro Tunc Assignment Jun 30, 2023
From: DEUTSCHES KREBSFORSCHUNGSZENTRUM; RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
To: NOVARTIS PHARMA AG
Reel/Frame 064132/0202 →